1
|
Gao ZD and Pan Q: Research progress in
relevance of HPV infection and non-cervical squamous cell
carcinoma. Zhong Liu Fang Zhi Za Zhi. 18:1816–1820. 2011.(In
Chinese).
|
2
|
Dayyani F, Etzel CJ, Liu M, et al:
Meta-analysis of the impact of human papillomavirus (HPV) on cancer
risk and overall survival in head and neck squamous cell carcinomas
(HNSCC). Head Neck Oncol. 2:152010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Syrjänen KJ and Syrjänen SM:
Papillomavirus Infections in Human Pathology. Wiley & Sons; New
York, NY: pp. 1–10. 2000
|
4
|
Cox JT: Human papillomavirus testing in
primary cervical screening and abnormal Papanicolaou management.
Obstet Gynecol Surv. 61(Suppl 1): S15–S25. 2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Muñoz N, Bosch FX, Castellsagué X, et al:
Against which human papillomavirus types shall we vaccinate and
screen? The international perspective. Int J Cancer. 111:278–285.
2004.
|
6
|
Kreimer AR, Clifford GM, Boyle P and
Franceschi S: Human papillomavirus types in head and neck squamous
cell carcinomas worldwide: a systematic review. Cancer Epidemiol
Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Muñoz N, Bosch FX, de Sanjosé S, et al:
Epidemiologic classification of human papillomavirus types
associated with cervical cancer. N Engl J Med. 348:518–527.
2003.
|
8
|
Saslow D, Castle PE, Cox JT, et al:
American Cancer Society Guideline for human papillomavirus (HPV)
vaccine use to prevent cervical cancer and its precursors. CA
Cancer J Clin. 57:7–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Joura EA, Leodolter S, Hernandez-Avila M,
et al: Efficacy of a quadrivalent prophylactic human papillomavirus
(types 6, 11, 16, and 18) L1 virus-like-particle vaccine against
high-grade vulval and vaginal lesions: a combined analysis of three
randomised clinical trials. Lancet. 369:1693–1702. 2007. View Article : Google Scholar
|
10
|
zur Hausen H: Papillomaviruses and cancer:
from basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002.PubMed/NCBI
|
11
|
Boyd AS, Stasko TS and Tang YW: Basaloid
squamous cell carcinoma of the skin. J Am Acad Dermatol.
64:144–151. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Cubilla AL, Lloveras B, Alejo M, et al:
The basaloid cell is the best tissue marker for human
papillomavirus in invasive penile squamous cell carcinoma: a study
of 202 cases from Paraguay. Am J Surg Pathol. 34:104–114. 2010.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Wong AK, Chan RC, Aggarwal N, et al: Human
papillomavirus genotypes in anal intraepithelial neoplasia and anal
carcinoma as detected in tissue biopsies. Mod Pathol. 23:144–150.
2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Miyashita M, Agdamag DM, Sasagawa T, et
al: High-risk HPV types in lesions of the uterine cervix of female
commercial sex workers in the Philippines. J Med Virol. 81:545–551.
2009. View Article : Google Scholar : PubMed/NCBI
|